Back to CVE records
High 8.8Published Aug 31, 2025

CVE-2025-9747A vulnerability has been found in Koillection up to 1.6.18.

Updated under an hour ago ()

Does this affect you?

It affects benjaminjonard koillection. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A vulnerability has been found in Koillection up to 1.6.18. Affected is an unknown function of the file assets/controllers/csrf_protection_controller.js. Such manipulation leads to cross-site request forgery. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 1.7.0 is able to address this issue. The name of the patch is 9ab8562d3f1e953da93fed63f9ee802c7ea26a9a. It is suggested to upgrade the affected component. The vendor explains: "I ended up switching to a newer CSRF handling using stateless token."

CVSS
8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-352, CWE-862
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Oct 19, 2026
First seen by InfoSec Signals
Oct 19, 2026

Affected products

Affected products
benjaminjonard koillection
benjaminjonard:koillection
before 1.7.0
NVD

References

  • patch
  • exploit, issue-tracking, third-party-advisory
  • exploit, issue-tracking, third-party-advisory
  • exploit, issue-tracking, third-party-advisory
  • release-notes
  • permissions-required, vdb-entry
  • third-party-advisory, vdb-entry
  • third-party-advisory, vdb-entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.